Stocktoria
INNOSPEC INC. IOSP
Nasdaq · XNAS · stock · Chemicals & Allied Products · website · IPO 1998-05-13
INNOSPEC INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.9B | $2.0B | $1.5B |
| Gross profit | $492.4M | $542.9M | $591.1M | $586.7M | $434.9M |
| R&D expense | $51.0M | $56.5M | $49.0M | $38.7M | $37.4M |
| SG&A expense | $285.1M | $305.3M | $380.5M | $360.7M | $267.2M |
| Operating income | $129.5M | $177.9M | $161.6M | $187.3M | $132.1M |
| Income tax | $21.5M | $5.6M | $35.3M | $51.6M | $41.3M |
| Operating cash flow | $138.3M | $184.5M | $207.3M | $81.7M | $93.2M |
| Cash & equivalents | $292.5M | $289.2M | $203.7M | $147.1M | $141.8M |
| Inventory | $329.3M | $301.0M | $300.1M | $373.1M | $277.6M |
| Total assets | $1.8B | $1.7B | $1.7B | $1.6B | $1.6B |
| Total liabilities | $499.5M | $518.6M | $557.8M | $563.3M | $537.9M |
| Shareholders' equity | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B |
| EPS (diluted) | $4.67 | $1.42 | $5.56 | $5.32 | $3.75 |
Source: SEC EDGAR filings · CIK 0001054905 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.